IND filing of tivoxavir marboxil represents final step for formal consideration by the Center for the Biomedical Advanced ...

IND filing of tivoxavir marboxil represents final step for formal consideration by the Center for the Biomedical Advanced ...

On track to define optimal dosing interval and advance manufacturing scale up of REYOBIQ for pivotal trial readiness in late ...

Optum notable drugs nearing FDA approval include Anaphylm, Sotyktu, and insulin icodec with decisions expected early 2026.

Braintree Laboratories, Inc. a part of Sebela Pharmaceuticals® and a leading manufacturer of gastroenterology pharmaceutical products, announced that it submitted a New Drug Application (NDA) on ...

One extra zero added to a bank check can mean the difference between losing $100 and losing $1,000. In many cases, such ...

Using the TDA7052A audio amplifier to generate a five octave, linear in pitch voltage-controlled oscillator (VCO).

Travere Therapeutics, Inc., (Nasdaq: TVTX) announced that today the U.S. Food and Drug Administration (FDA) has extended the review timeline of its supplemental New Drug Application (sNDA) for ...

The nation’s highest court has agreed to hear arguments in a 401(k) case involving alternative investments and the need for a “meaningful benchmark.” ...

Tsiri was dismissed in August 2022 after approving a payment of R2 847.14 instead of the correct amount of R2 482, a ...

Schrödinger, Inc. (Nasdaq: SDGR) provided an update on its progress across the business in 2025 and announced its strategic ...

Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...